A Phase 1 Trial of Targeted DSG3-CAART Cell Therapy in Mucosal-Dominant Pemphigus Vulgaris (mPV) Patients: Early Cohort Data Chang, D. J., Basu, S., Porter, D., Abedi, M., Weng, W., Micheletti, R., Maverakis, E., Marinkovich, M., Bryer, J., Downing, L., Bagci, I., Hoffman, K., Volkov, J., Nunez, D., Milone, M., Payne, A. S. CELL PRESS. 2022: 373

View details for Web of Science ID 000794043701395